Therapeutic options in recurrent glioblastoma—An update
نویسندگان
چکیده
منابع مشابه
Update on therapeutic options in Waldenström macroglobulinemia.
Waldenström macroglobulinemia (WM) is a B-cell disorder characterized primarily by bone marrow infiltration with lymphoplasmacytic cells (LPCs), along with demonstration of an IgM monoclonal gammopathy in the blood. WM remains incurable, with 5-6 yr median overall survival for patients with symptomatic WM. The main therapeutic options include alkylating agents, nucleoside analogues, and rituxim...
متن کاملHeart Failure: Update on Therapeutic Options
Heart failure statistics are daunting: 550,000 new cases each year, a 1-year mortality rate of nearly 20%, and annual direct and indirect costs that total $24.3 billion.1 The diverse etiology of heart failure and the complex, progressive course of the disease can make treatment decisions daunting as well. Here I discuss current recommendations for heart failure management, as well as the clinic...
متن کاملRecurrent herpes simplex labialis: selected therapeutic options.
Recurrent infection with herpes simplex virus 1 (HSV1), called herpes simplex labialis (HSL), is a global problem for patients with normal immune systems. An effective management program is needed for those with frequent HSL recurrences, particularly if associated morbidity and life-threatening factors are present and the patient's immune status is altered. Over the past 20 years, a variety of ...
متن کاملTherapeutic options in the management of colon cancer: 2005 update.
Recently, major developments in the treatment of colon cancer have emerged. These developments include improvements in surgical technique and staging and the introduction of new molecularly targeted pharmacologic agents. Improvements in surgical management involve enhanced staging techniques, allowing more accurate determination of risk of recurrence. Newer agents, such as oxaliplatin, cetuxima...
متن کاملUpdate on new therapeutic options for the somatopause.
During the last decade, a significant body of evidence has accumulated, indicating that the declining activity of the GH-IGF-I axis with aging might play a role in the development of frailty and in several pathological conditions commonly seen during aging, such as atherosclerosis, cardiovascular disease, and cognitive decline. GH therapy has become widely popular as antiaging therapy in order ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Critical Reviews in Oncology/Hematology
سال: 2016
ISSN: 1040-8428
DOI: 10.1016/j.critrevonc.2016.01.018